Close Menu

NEW YORK — Korean rare disease diagnostics firm 3billion said this week that it has raised $10 million in a Series B financing round.

The round was led by Korea Development Bank and included existing investors The Wells Investment and JW Asset, as well as new investors Magna Investment, Daekyo Investment, Yuanta Investment, D3 Jubilee Partners, Shinhan Capital, Nvestor, and Aventures Investment.  

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.